bioAffinity Technologies (BIAF) Interest Expenses (2021 - 2026)

bioAffinity Technologies has disclosed Interest Expenses across 6 years of filings, most recently posting $8938.0 for Q1 2026.

• In Q1 2026, Interest Expenses fell 42.28% year-over-year to $8938.0; the TTM figure through Mar 2026 stood at $966946.0 (up 1743.94% YoY), while the FY2025 annual figure was $502429.0, up 4828.67% from the prior year.
• Interest Expenses eased to $8938.0 in Q1 2026, from $471126.0 in the prior quarter.
• Over the last five years, Interest Expenses for BIAF reached as high as $896502.0 in Q3 2022 and fell as low as $8.0 in Q4 2024.
• The 5-year median for Interest Expenses is $15091.0 (2024), against an average of $153694.6.
• Annual changes were most pronounced in 2024 — Interest Expenses slumped 99.94% — and 2025, when it jumped 5888975.0%.
• A 5-year view of Interest Expenses shows it stood at $89290.0 in 2022, then sank by 84.3% to $14021.0 in 2023, then tumbled by 99.94% to $8.0 in 2024, then jumped by 5888975.0% to $471126.0 in 2025, then tumbled by 98.1% to $8938.0 in 2026.
• According to Business Quant data, Interest Expenses over the past three periods registered $8938.0, $471126.0, and $3839.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.